REYON Pharmaceutical Co., Ltd. (KRX:102460)
South Korea
· Delayed Price · Currency is KRW 11,140
-40 (-0.36%)
At close: Apr 29, 2026
REYON Pharmaceutical Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | -29,633 | 4,151 | 3,583 | 7,434 | 5,537 | Upgrade
|
| Depreciation & Amortization | 31,794 | 6,344 | 4,782 | 4,534 | 4,666 | Upgrade
|
| Loss (Gain) From Sale of Assets | 1.84 | 39.08 | -1.68 | -24.41 | 140.92 | Upgrade
|
| Loss (Gain) From Sale of Investments | -935.89 | -387.54 | 2,453 | -4,262 | -1,125 | Upgrade
|
| Loss (Gain) on Equity Investments | -1,688 | 4,359 | 960.18 | 1,968 | -1,684 | Upgrade
|
| Provision & Write-off of Bad Debts | 19.64 | 24.63 | -63.38 | -79.34 | 467.28 | Upgrade
|
| Other Operating Activities | -4,279 | -17,529 | -439.2 | -1,749 | 1,895 | Upgrade
|
| Change in Accounts Receivable | 2,318 | 3,226 | 1,947 | -1,134 | -986.61 | Upgrade
|
| Change in Inventory | 4,061 | -3,470 | -5,067 | -3,677 | 2,005 | Upgrade
|
| Change in Accounts Payable | -1,362 | 1,807 | 3,394 | 61.52 | 563.61 | Upgrade
|
| Change in Income Taxes | - | - | -342.94 | - | - | Upgrade
|
| Change in Other Net Operating Assets | 1,160 | 0.96 | -1,781 | 4,460 | 199.4 | Upgrade
|
| Operating Cash Flow | 1,457 | -1,436 | 8,645 | 8,729 | 11,685 | Upgrade
|
| Operating Cash Flow Growth | - | - | -0.96% | -25.29% | 154.04% | Upgrade
|
| Capital Expenditures | -7,916 | -16,012 | -28,870 | -63,133 | -116,978 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.82 | - | 1.72 | 42.27 | 8 | Upgrade
|
| Sale (Purchase) of Intangibles | 120 | 488.93 | -2.5 | - | -18.7 | Upgrade
|
| Investment in Securities | -493.96 | -1,081 | 19,979 | 10,566 | 2,076 | Upgrade
|
| Other Investing Activities | 951.61 | 13 | 152.12 | -38.93 | 231.1 | Upgrade
|
| Investing Cash Flow | -7,337 | -16,591 | -8,739 | -52,564 | -114,682 | Upgrade
|
| Short-Term Debt Issued | 12,000 | 3,000 | - | - | 3,500 | Upgrade
|
| Long-Term Debt Issued | - | 85,000 | 13,100 | 113,900 | 150,100 | Upgrade
|
| Total Debt Issued | 12,000 | 88,000 | 13,100 | 113,900 | 153,600 | Upgrade
|
| Long-Term Debt Repaid | -9,637 | -81,121 | -2,205 | -116,104 | -2,475 | Upgrade
|
| Total Debt Repaid | -9,637 | -81,121 | -2,205 | -116,104 | -2,475 | Upgrade
|
| Net Debt Issued (Repaid) | 2,363 | 6,879 | 10,895 | -2,204 | 151,125 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | 10,000 | Upgrade
|
| Repurchase of Common Stock | - | - | - | - | -76.31 | Upgrade
|
| Dividends Paid | - | -2,751 | -2,738 | -4,563 | -3,464 | Upgrade
|
| Other Financing Activities | - | -0 | -3.83 | - | -9.23 | Upgrade
|
| Financing Cash Flow | 2,363 | 4,128 | 8,153 | -6,767 | 157,576 | Upgrade
|
| Foreign Exchange Rate Adjustments | -24.58 | 0.21 | -1.28 | -89.04 | -34 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | -0 | - | -0 | -0 | -0 | Upgrade
|
| Net Cash Flow | -3,542 | -13,898 | 8,058 | -50,691 | 54,544 | Upgrade
|
| Free Cash Flow | -6,459 | -17,448 | -20,225 | -54,404 | -105,293 | Upgrade
|
| Free Cash Flow Margin | -4.43% | -11.77% | -13.39% | -35.32% | -73.73% | Upgrade
|
| Free Cash Flow Per Share | -352.23 | -949.87 | -1102.71 | -2979.96 | -5942.30 | Upgrade
|
| Cash Interest Paid | 6,659 | 8,478 | 195.52 | 124.02 | 93.37 | Upgrade
|
| Cash Income Tax Paid | -191.95 | 1,315 | 950.65 | 1,188 | -1,488 | Upgrade
|
| Levered Free Cash Flow | -15,601 | 7,306 | -25,600 | -61,372 | -109,157 | Upgrade
|
| Unlevered Free Cash Flow | -7,344 | 8,089 | -25,477 | -61,296 | -109,087 | Upgrade
|
| Change in Working Capital | 6,177 | 1,563 | -1,851 | -290.36 | 1,782 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.